Aditi Hazra

Dr. Hazra received her PhD in cancer biology from The University of Texas M.D. Anderson Cancer Center and was a post-doctoral fellow in the Program in Molecular and Genetic Epidemiology at the Harvard T.H. Chan School of Public Health. To identify clinically actionable biomarkers, she has led translational and collaborative research on gene regulation in cancer, including studies on germline genetic risk, nutritional genomics, cancer genomics and epigenomics. Her current research is on breast cancer genomics and her future goals are to design a strength training survivorship trial in partnership with the community. Dr. Hazra’s American Cancer Society funded research aims to evaluate the transcriptome and improve stratification of subsequent breast cancer risk among racially diverse DCIS (ductal carcinoma in situ) patients. The completion of the “precision health equity” aims may lead to personalized treatment for all DCIS patients and may prevent DCIS progression to invasive breast cancer. As a Fulbright Specialist candidate in global health, Dr. Hazra aims to improve awareness, early detection of breast cancer, and survivorship for all women.

Education

• MPH: University of Texas, Houston
• PhD: UT M.D. Anderson Cancer and UT Graduate School of Biomedical Sciences

Companies

• Founder STARS Exercise (2021)
• Cancer Scientist U.S. Department of Veterans Affairs Boston (2020)
• Instructor Harvard University (2020)
• Assistant Professor of Medicine Harvard Medical School and Brigham and Women's Hospital (2016)
• Associate Member Broad Institute (2015)
• Assistant Professor in the Department of Epidemiology Harvard School of Public Health (2013)
• President and Founder PinkSari, Inc. (2011)
• Instructor in Epidemiology Harvard School of Public Health (2008 — 2011)